

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.46496091 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.46496091 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.14789189 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.14789189 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.74996414 |
| 6 | epoxygenase P450 pathway (GO:0019373) | 6.61956960 |
| 7 | omega-hydroxylase P450 pathway (GO:0097267) | 6.38947455 |
| 8 | tryptophan catabolic process (GO:0006569) | 6.12513559 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 6.12513559 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 6.12513559 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.03408381 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.92492950 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.82643333 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.79531992 |
| 15 | tryptophan metabolic process (GO:0006568) | 5.76003331 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.62682308 |
| 17 | cysteine metabolic process (GO:0006534) | 5.61162328 |
| 18 | ethanol metabolic process (GO:0006067) | 5.57005754 |
| 19 | urea cycle (GO:0000050) | 5.55805758 |
| 20 | urea metabolic process (GO:0019627) | 5.55805758 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 5.48128743 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.24060657 |
| 23 | serine family amino acid catabolic process (GO:0009071) | 5.21653189 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 5.20943237 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 5.11638373 |
| 26 | complement activation, alternative pathway (GO:0006957) | 5.09156168 |
| 27 | drug metabolic process (GO:0017144) | 5.06662072 |
| 28 | regulation of protein activation cascade (GO:2000257) | 5.04495684 |
| 29 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.04048778 |
| 30 | protein carboxylation (GO:0018214) | 5.04048778 |
| 31 | homocysteine metabolic process (GO:0050667) | 5.03367671 |
| 32 | regulation of fibrinolysis (GO:0051917) | 5.01328733 |
| 33 | lysine metabolic process (GO:0006553) | 4.95669886 |
| 34 | lysine catabolic process (GO:0006554) | 4.95669886 |
| 35 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.95661245 |
| 36 | bile acid metabolic process (GO:0008206) | 4.95259269 |
| 37 | aromatic amino acid family metabolic process (GO:0009072) | 4.89854230 |
| 38 | regulation of complement activation (GO:0030449) | 4.71917813 |
| 39 | amino-acid betaine metabolic process (GO:0006577) | 4.70485101 |
| 40 | tyrosine metabolic process (GO:0006570) | 4.69732957 |
| 41 | * alpha-amino acid catabolic process (GO:1901606) | 4.65617822 |
| 42 | oxidative demethylation (GO:0070989) | 4.64777874 |
| 43 | reverse cholesterol transport (GO:0043691) | 4.64707554 |
| 44 | regulation of cholesterol esterification (GO:0010872) | 4.63943861 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 4.60851994 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 4.55280159 |
| 47 | macromolecular complex remodeling (GO:0034367) | 4.55280159 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 4.55280159 |
| 49 | cellular ketone body metabolic process (GO:0046950) | 4.41683502 |
| 50 | negative regulation of sterol transport (GO:0032372) | 4.40452410 |
| 51 | negative regulation of cholesterol transport (GO:0032375) | 4.40452410 |
| 52 | acylglycerol homeostasis (GO:0055090) | 4.39036376 |
| 53 | triglyceride homeostasis (GO:0070328) | 4.39036376 |
| 54 | glutamate metabolic process (GO:0006536) | 4.38423167 |
| 55 | * cellular amino acid catabolic process (GO:0009063) | 4.33535232 |
| 56 | glycine metabolic process (GO:0006544) | 4.32805457 |
| 57 | indolalkylamine metabolic process (GO:0006586) | 4.31827120 |
| 58 | phospholipid efflux (GO:0033700) | 4.29699906 |
| 59 | serine family amino acid metabolic process (GO:0009069) | 4.28618815 |
| 60 | cellular biogenic amine catabolic process (GO:0042402) | 4.24658727 |
| 61 | amine catabolic process (GO:0009310) | 4.24658727 |
| 62 | cellular glucuronidation (GO:0052695) | 4.23291945 |
| 63 | bile acid and bile salt transport (GO:0015721) | 4.20007936 |
| 64 | plasma lipoprotein particle clearance (GO:0034381) | 4.19127278 |
| 65 | ethanol oxidation (GO:0006069) | 4.16401813 |
| 66 | drug catabolic process (GO:0042737) | 4.15752224 |
| 67 | imidazole-containing compound metabolic process (GO:0052803) | 4.14592787 |
| 68 | serine family amino acid biosynthetic process (GO:0009070) | 4.11745127 |
| 69 | benzene-containing compound metabolic process (GO:0042537) | 4.10901531 |
| 70 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.09008299 |
| 71 | S-adenosylmethionine metabolic process (GO:0046500) | 3.98167784 |
| 72 | low-density lipoprotein particle remodeling (GO:0034374) | 3.98096509 |
| 73 | * cellular modified amino acid catabolic process (GO:0042219) | 3.97432958 |
| 74 | arginine metabolic process (GO:0006525) | 3.96496135 |
| 75 | cholesterol efflux (GO:0033344) | 3.96177164 |
| 76 | short-chain fatty acid metabolic process (GO:0046459) | 3.91313332 |
| 77 | acetyl-CoA metabolic process (GO:0006084) | 3.87642145 |
| 78 | aldehyde catabolic process (GO:0046185) | 3.86850015 |
| 79 | protein activation cascade (GO:0072376) | 3.84272724 |
| 80 | plasma lipoprotein particle assembly (GO:0034377) | 3.83925253 |
| 81 | alkaloid metabolic process (GO:0009820) | 3.83865227 |
| 82 | ketone body metabolic process (GO:1902224) | 3.83179737 |
| 83 | phenylpropanoid metabolic process (GO:0009698) | 3.80743787 |
| 84 | * organic acid catabolic process (GO:0016054) | 3.80042037 |
| 85 | * carboxylic acid catabolic process (GO:0046395) | 3.80042037 |
| 86 | uronic acid metabolic process (GO:0006063) | 3.78733339 |
| 87 | glucuronate metabolic process (GO:0019585) | 3.78733339 |
| 88 | fibrinolysis (GO:0042730) | 3.74919490 |
| 89 | regulation of cholesterol homeostasis (GO:2000188) | 3.74574440 |
| 90 | fatty acid homeostasis (GO:0055089) | 3.71949188 |
| 91 | regulation of bile acid biosynthetic process (GO:0070857) | 3.71835343 |
| 92 | phospholipid homeostasis (GO:0055091) | 3.71701496 |
| 93 | response to mercury ion (GO:0046689) | 3.70979853 |
| 94 | exogenous drug catabolic process (GO:0042738) | 3.70802526 |
| 95 | aspartate family amino acid catabolic process (GO:0009068) | 3.70734116 |
| 96 | urate metabolic process (GO:0046415) | 3.69949583 |
| 97 | drug transmembrane transport (GO:0006855) | 3.67377099 |
| 98 | triglyceride catabolic process (GO:0019433) | 3.67011544 |
| 99 | xenobiotic catabolic process (GO:0042178) | 3.65109704 |
| 100 | negative regulation of protein activation cascade (GO:2000258) | 3.64923699 |
| 101 | regulation of plasminogen activation (GO:0010755) | 3.64309201 |
| 102 | oxaloacetate metabolic process (GO:0006107) | 3.64131097 |
| 103 | 2-oxoglutarate metabolic process (GO:0006103) | 3.63344671 |
| 104 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.62844610 |
| 105 | cholesterol homeostasis (GO:0042632) | 3.61826755 |
| 106 | daunorubicin metabolic process (GO:0044597) | 3.60252050 |
| 107 | polyketide metabolic process (GO:0030638) | 3.60252050 |
| 108 | doxorubicin metabolic process (GO:0044598) | 3.60252050 |
| 109 | positive regulation of lipid catabolic process (GO:0050996) | 3.59475398 |
| 110 | * coenzyme catabolic process (GO:0009109) | 3.58380886 |
| 111 | sterol homeostasis (GO:0055092) | 3.56690953 |
| 112 | flavonoid metabolic process (GO:0009812) | 3.56108889 |
| 113 | blood coagulation, intrinsic pathway (GO:0007597) | 3.54476618 |
| 114 | complement activation, classical pathway (GO:0006958) | 3.53726971 |
| 115 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.52874520 |
| 116 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.52874520 |
| 117 | complement activation (GO:0006956) | 3.52700001 |
| 118 | monocarboxylic acid catabolic process (GO:0072329) | 3.52671118 |
| 119 | negative regulation of lipase activity (GO:0060192) | 3.51844113 |
| 120 | acylglycerol catabolic process (GO:0046464) | 3.51658604 |
| 121 | neutral lipid catabolic process (GO:0046461) | 3.51658604 |
| 122 | primary alcohol metabolic process (GO:0034308) | 3.48476224 |
| 123 | biotin metabolic process (GO:0006768) | 3.48076030 |
| 124 | primary alcohol catabolic process (GO:0034310) | 3.40558234 |
| 125 | negative regulation of blood coagulation (GO:0030195) | 3.39756076 |
| 126 | negative regulation of hemostasis (GO:1900047) | 3.39756076 |
| 127 | intestinal cholesterol absorption (GO:0030299) | 3.37109035 |
| 128 | regulation of humoral immune response (GO:0002920) | 3.36514316 |
| 129 | regulation of sequestering of triglyceride (GO:0010889) | 3.35996612 |
| 130 | acute-phase response (GO:0006953) | 3.35042252 |
| 131 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.27898000 |
| 132 | fatty acid transmembrane transport (GO:1902001) | 3.26494730 |
| 133 | opsonization (GO:0008228) | 3.22102413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.21647190 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.02461595 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.64315027 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.39053883 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.14377310 |
| 6 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.10907878 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.79229988 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.99049495 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.78467280 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.12047357 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.10400129 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.6873979 |
| 13 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.96343183 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.94544539 |
| 15 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.74926994 |
| 16 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.71034251 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.70348159 |
| 18 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.63731798 |
| 19 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.45429653 |
| 20 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.41527498 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.41273234 |
| 22 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.34758088 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33063248 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.21995310 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 1.21602432 |
| 26 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.16697675 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16130104 |
| 28 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.14525185 |
| 29 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09940355 |
| 30 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.07391422 |
| 31 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03478165 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.01825583 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.01117682 |
| 34 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.00205293 |
| 35 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98712588 |
| 36 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.98676084 |
| 37 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.96597332 |
| 38 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.96582644 |
| 39 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95783858 |
| 40 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94955712 |
| 41 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.93648904 |
| 42 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.92835398 |
| 43 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.92233493 |
| 44 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.91029672 |
| 45 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.90705463 |
| 46 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.89762691 |
| 47 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.89477530 |
| 48 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.89463399 |
| 49 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.89312943 |
| 50 | STAT3_23295773_ChIP-Seq_U87_Human | 0.88314001 |
| 51 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.86713202 |
| 52 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.85842142 |
| 53 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85815849 |
| 54 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.85114333 |
| 55 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.84586920 |
| 56 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.83682915 |
| 57 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82905702 |
| 58 | TCF4_23295773_ChIP-Seq_U87_Human | 0.82382369 |
| 59 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82325336 |
| 60 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.82027724 |
| 61 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.81226278 |
| 62 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.79657677 |
| 63 | AR_25329375_ChIP-Seq_VCAP_Human | 0.78806785 |
| 64 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.78604114 |
| 65 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.78604114 |
| 66 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.78327538 |
| 67 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.77566180 |
| 68 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.77309023 |
| 69 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.76718556 |
| 70 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76574195 |
| 71 | VDR_22108803_ChIP-Seq_LS180_Human | 0.76241050 |
| 72 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.75924091 |
| 73 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75800323 |
| 74 | * SOX2_21211035_ChIP-Seq_LN229_Human | 0.75696628 |
| 75 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.75519919 |
| 76 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75398614 |
| 77 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.75280944 |
| 78 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.74393173 |
| 79 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.74370938 |
| 80 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.74216432 |
| 81 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.72868128 |
| 82 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.72862319 |
| 83 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72776342 |
| 84 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.72279125 |
| 85 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.71561984 |
| 86 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.71363162 |
| 87 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.71123092 |
| 88 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.71057368 |
| 89 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.70923699 |
| 90 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.70733737 |
| 91 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.70733737 |
| 92 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.70668814 |
| 93 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 0.70388987 |
| 94 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 0.70388987 |
| 95 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.70117225 |
| 96 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.70117106 |
| 97 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.70034829 |
| 98 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.69663072 |
| 99 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.69393068 |
| 100 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.69269752 |
| 101 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.69260001 |
| 102 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.69260001 |
| 103 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.68108559 |
| 104 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.67852912 |
| 105 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.66975134 |
| 106 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.64924375 |
| 107 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.64382983 |
| 108 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.63230826 |
| 109 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.62195098 |
| 110 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.60608509 |
| 111 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.60204605 |
| 112 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.60115002 |
| 113 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.57764218 |
| 114 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56564443 |
| 115 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.54735389 |
| 116 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54414545 |
| 117 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.53746384 |
| 118 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53683154 |
| 119 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.53627292 |
| 120 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.52938962 |
| 121 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52684819 |
| 122 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52357172 |
| 123 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.51302097 |
| 124 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.50482830 |
| 125 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49867444 |
| 126 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49251259 |
| 127 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.49162622 |
| 128 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.48314237 |
| 129 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.47676334 |
| 130 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.46467841 |
| 131 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.45494260 |
| 132 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45364346 |
| 133 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.45361350 |
| 134 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.45041289 |
| 135 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.45029415 |
| 136 | GATA1_19941826_ChIP-Seq_K562_Human | 0.43380587 |
| 137 | GATA2_19941826_ChIP-Seq_K562_Human | 0.42950808 |
| 138 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.42946347 |
| 139 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42846816 |
| 140 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.42661685 |
| 141 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.42625456 |
| 142 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.41597150 |
| 143 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.41507725 |
| 144 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.40984755 |
| 145 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.40678053 |
| 146 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.39165901 |
| 147 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.38384793 |
| 148 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.37227030 |
| 149 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.37109166 |
| 150 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.36991475 |
| 151 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.36757591 |
| 152 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.36675170 |
| 153 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.36351419 |
| 154 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.36126958 |
| 155 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.36003716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.14168270 |
| 2 | MP0005360_urolithiasis | 7.72892804 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.24049695 |
| 4 | MP0005365_abnormal_bile_salt | 6.07003817 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.12058562 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.08199198 |
| 7 | MP0003252_abnormal_bile_duct | 3.82974752 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.56055582 |
| 9 | MP0009840_abnormal_foam_cell | 3.19540488 |
| 10 | MP0005332_abnormal_amino_acid | 3.03145395 |
| 11 | MP0005083_abnormal_biliary_tract | 2.98317730 |
| 12 | MP0003195_calcinosis | 2.88642556 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.62024419 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.37836469 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.27187530 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.13145147 |
| 17 | MP0000609_abnormal_liver_physiology | 2.11653142 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 1.98206105 |
| 19 | MP0005319_abnormal_enzyme/_coenzyme | 1.84195466 |
| 20 | MP0003868_abnormal_feces_composition | 1.83711651 |
| 21 | MP0003646_muscle_fatigue | 1.66518944 |
| 22 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.64732991 |
| 23 | MP0001764_abnormal_homeostasis | 1.63972695 |
| 24 | MP0009643_abnormal_urine_homeostasis | 1.42682630 |
| 25 | MP0003011_delayed_dark_adaptation | 1.41514830 |
| 26 | MP0003879_abnormal_hair_cell | 1.38504979 |
| 27 | MP0009697_abnormal_copulation | 1.37183453 |
| 28 | MP0003186_abnormal_redox_activity | 1.36588934 |
| 29 | MP0005451_abnormal_body_composition | 1.32882344 |
| 30 | MP0001984_abnormal_olfaction | 1.27766340 |
| 31 | MP0000751_myopathy | 1.25721051 |
| 32 | MP0004145_abnormal_muscle_electrophysio | 1.19767382 |
| 33 | MP0003705_abnormal_hypodermis_morpholog | 1.19523128 |
| 34 | MP0002254_reproductive_system_inflammat | 1.15804436 |
| 35 | MP0000598_abnormal_liver_morphology | 1.13459970 |
| 36 | MP0005647_abnormal_sex_gland | 1.11433806 |
| 37 | MP0000604_amyloidosis | 1.11193095 |
| 38 | MP0003656_abnormal_erythrocyte_physiolo | 1.11002428 |
| 39 | MP0005670_abnormal_white_adipose | 1.10430965 |
| 40 | MP0009780_abnormal_chondrocyte_physiolo | 1.10022878 |
| 41 | MP0005636_abnormal_mineral_homeostasis | 1.06643130 |
| 42 | MP0009764_decreased_sensitivity_to | 1.03917807 |
| 43 | MP0000749_muscle_degeneration | 1.01741629 |
| 44 | MP0005375_adipose_tissue_phenotype | 1.00731114 |
| 45 | MP0002638_abnormal_pupillary_reflex | 0.97069533 |
| 46 | MP0009763_increased_sensitivity_to | 0.94627443 |
| 47 | MP0004036_abnormal_muscle_relaxation | 0.90507617 |
| 48 | MP0005551_abnormal_eye_electrophysiolog | 0.90315978 |
| 49 | MP0002332_abnormal_exercise_endurance | 0.89653795 |
| 50 | MP0009642_abnormal_blood_homeostasis | 0.87403436 |
| 51 | MP0002876_abnormal_thyroid_physiology | 0.87396908 |
| 52 | MP0005423_abnormal_somatic_nervous | 0.87298074 |
| 53 | MP0003690_abnormal_glial_cell | 0.86224971 |
| 54 | MP0001501_abnormal_sleep_pattern | 0.85301198 |
| 55 | MP0006036_abnormal_mitochondrial_physio | 0.83928169 |
| 56 | MP0008469_abnormal_protein_level | 0.83618620 |
| 57 | MP0004130_abnormal_muscle_cell | 0.82394045 |
| 58 | MP0005084_abnormal_gallbladder_morpholo | 0.81874243 |
| 59 | MP0002078_abnormal_glucose_homeostasis | 0.79809619 |
| 60 | MP0002971_abnormal_brown_adipose | 0.79653598 |
| 61 | MP0004215_abnormal_myocardial_fiber | 0.79347711 |
| 62 | MP0010368_abnormal_lymphatic_system | 0.79308070 |
| 63 | MP0003329_amyloid_beta_deposits | 0.78458244 |
| 64 | MP0005535_abnormal_body_temperature | 0.77784257 |
| 65 | MP0004270_analgesia | 0.77479859 |
| 66 | MP0001756_abnormal_urination | 0.77012516 |
| 67 | MP0009745_abnormal_behavioral_response | 0.76825282 |
| 68 | MP0003959_abnormal_lean_body | 0.76595776 |
| 69 | MP0003633_abnormal_nervous_system | 0.76417904 |
| 70 | MP0005408_hypopigmentation | 0.76282508 |
| 71 | MP0006138_congestive_heart_failure | 0.76252717 |
| 72 | MP0005376_homeostasis/metabolism_phenot | 0.76142073 |
| 73 | MP0001486_abnormal_startle_reflex | 0.76140776 |
| 74 | MP0002132_abnormal_respiratory_system | 0.74673871 |
| 75 | MP0009765_abnormal_xenobiotic_induced | 0.73228620 |
| 76 | MP0002064_seizures | 0.72858405 |
| 77 | MP0005220_abnormal_exocrine_pancreas | 0.72831260 |
| 78 | MP0005646_abnormal_pituitary_gland | 0.72662831 |
| 79 | MP0005452_abnormal_adipose_tissue | 0.72400888 |
| 80 | MP0005334_abnormal_fat_pad | 0.71487010 |
| 81 | MP0001661_extended_life_span | 0.71365175 |
| 82 | MP0003880_abnormal_central_pattern | 0.68987329 |
| 83 | MP0001986_abnormal_taste_sensitivity | 0.68426242 |
| 84 | MP0002272_abnormal_nervous_system | 0.67355075 |
| 85 | MP0002909_abnormal_adrenal_gland | 0.66907265 |
| 86 | MP0002269_muscular_atrophy | 0.61668057 |
| 87 | MP0005266_abnormal_metabolism | 0.61104798 |
| 88 | MP0002736_abnormal_nociception_after | 0.60733741 |
| 89 | MP0002136_abnormal_kidney_physiology | 0.60511901 |
| 90 | MP0004087_abnormal_muscle_fiber | 0.58978920 |
| 91 | MP0001502_abnormal_circadian_rhythm | 0.58043057 |
| 92 | MP0005448_abnormal_energy_balance | 0.57851013 |
| 93 | MP0005666_abnormal_adipose_tissue | 0.57186981 |
| 94 | MP0001440_abnormal_grooming_behavior | 0.56857531 |
| 95 | MP0004185_abnormal_adipocyte_glucose | 0.56605199 |
| 96 | MP0009053_abnormal_anal_canal | 0.56130391 |
| 97 | MP0004043_abnormal_pH_regulation | 0.55493167 |
| 98 | MP0006035_abnormal_mitochondrial_morpho | 0.55176620 |
| 99 | MP0003631_nervous_system_phenotype | 0.54412562 |
| 100 | MP0000747_muscle_weakness | 0.53903692 |
| 101 | MP0001968_abnormal_touch/_nociception | 0.53873643 |
| 102 | MP0000639_abnormal_adrenal_gland | 0.53641436 |
| 103 | MP0005620_abnormal_muscle_contractility | 0.53383853 |
| 104 | MP0003638_abnormal_response/metabolism_ | 0.52390201 |
| 105 | MP0004924_abnormal_behavior | 0.51523210 |
| 106 | MP0005386_behavior/neurological_phenoty | 0.51523210 |
| 107 | MP0003075_altered_response_to | 0.50965061 |
| 108 | MP0005395_other_phenotype | 0.48595005 |
| 109 | MP0002928_abnormal_bile_duct | 0.46893288 |
| 110 | MP0008874_decreased_physiological_sensi | 0.46304125 |
| 111 | MP0003953_abnormal_hormone_level | 0.45599195 |
| 112 | MP0002822_catalepsy | 0.45271407 |
| 113 | MP0008872_abnormal_physiological_respon | 0.43965407 |
| 114 | MP0005464_abnormal_platelet_physiology | 0.43357531 |
| 115 | MP0004782_abnormal_surfactant_physiolog | 0.42610650 |
| 116 | MP0009384_cardiac_valve_regurgitation | 0.42327345 |
| 117 | MP0005166_decreased_susceptibility_to | 0.40111024 |
| 118 | MP0009115_abnormal_fat_cell | 0.39581228 |
| 119 | MP0002168_other_aberrant_phenotype | 0.39128190 |
| 120 | MP0008873_increased_physiological_sensi | 0.38156978 |
| 121 | MP0000230_abnormal_systemic_arterial | 0.38126937 |
| 122 | MP0001765_abnormal_ion_homeostasis | 0.37770698 |
| 123 | MP0005248_abnormal_Harderian_gland | 0.37600193 |
| 124 | MP0003718_maternal_effect | 0.36957626 |
| 125 | MP0002796_impaired_skin_barrier | 0.36800577 |
| 126 | MP0002837_dystrophic_cardiac_calcinosis | 0.36085997 |
| 127 | MP0005167_abnormal_blood-brain_barrier | 0.35867745 |
| 128 | MP0005058_abnormal_lysosome_morphology | 0.35493897 |
| 129 | MP0009672_abnormal_birth_weight | 0.35344950 |
| 130 | MP0003724_increased_susceptibility_to | 0.34400251 |
| 131 | MP0002970_abnormal_white_adipose | 0.33296564 |
| 132 | MP0000579_abnormal_nail_morphology | 0.32501058 |
| 133 | MP0001881_abnormal_mammary_gland | 0.29743697 |
| 134 | MP0003436_decreased_susceptibility_to | 0.29388694 |
| 135 | MP0000249_abnormal_blood_vessel | 0.28673290 |
| 136 | MP0001853_heart_inflammation | 0.28421512 |
| 137 | MP0004381_abnormal_hair_follicle | 0.28238222 |
| 138 | MP0002090_abnormal_vision | 0.27786433 |
| 139 | MP0002135_abnormal_kidney_morphology | 0.27164025 |
| 140 | MP0004883_abnormal_blood_vessel | 0.25666349 |
| 141 | MP0005595_abnormal_vascular_smooth | 0.25071582 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.21707214 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.02569108 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.00892658 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.46719334 |
| 5 | Xanthomatosis (HP:0000991) | 6.19965315 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.13771455 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.06040892 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.38443660 |
| 9 | Complement deficiency (HP:0004431) | 5.11890577 |
| 10 | Hyperammonemia (HP:0001987) | 4.72676558 |
| 11 | Hyperglycinemia (HP:0002154) | 4.62751838 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.60045155 |
| 13 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.57403225 |
| 14 | Joint hemorrhage (HP:0005261) | 4.52703353 |
| 15 | Hyperglycinuria (HP:0003108) | 4.48858477 |
| 16 | Ketosis (HP:0001946) | 4.47918866 |
| 17 | Epidermoid cyst (HP:0200040) | 4.43481390 |
| 18 | Abnormality of glycine metabolism (HP:0010895) | 4.34404043 |
| 19 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.34404043 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.30907686 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.23270507 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.20155710 |
| 23 | Abnormality of the common coagulation pathway (HP:0010990) | 4.15640208 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 4.12407794 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 4.07127740 |
| 26 | Fat malabsorption (HP:0002630) | 3.99030229 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.81327338 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.71498325 |
| 29 | Abnormality of complement system (HP:0005339) | 3.68579630 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.58164404 |
| 31 | Nephritis (HP:0000123) | 3.53106925 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.52609459 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.50264150 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.48510050 |
| 35 | Ketoacidosis (HP:0001993) | 3.35954218 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.34080144 |
| 37 | Delayed CNS myelination (HP:0002188) | 3.28727482 |
| 38 | Abnormality of nucleobase metabolism (HP:0010932) | 3.23622185 |
| 39 | Hyperbilirubinemia (HP:0002904) | 3.22389048 |
| 40 | Abnormality of serum amino acid levels (HP:0003112) | 3.14702108 |
| 41 | Gout (HP:0001997) | 3.03941970 |
| 42 | Abnormality of purine metabolism (HP:0004352) | 2.99684116 |
| 43 | Steatorrhea (HP:0002570) | 2.97971897 |
| 44 | Hepatocellular carcinoma (HP:0001402) | 2.94423462 |
| 45 | Myocardial infarction (HP:0001658) | 2.89209773 |
| 46 | Metabolic acidosis (HP:0001942) | 2.86511651 |
| 47 | Exercise-induced myalgia (HP:0003738) | 2.81534300 |
| 48 | Spontaneous abortion (HP:0005268) | 2.77845033 |
| 49 | Skin nodule (HP:0200036) | 2.72227426 |
| 50 | Lethargy (HP:0001254) | 2.70307931 |
| 51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.69226332 |
| 52 | Dicarboxylic aciduria (HP:0003215) | 2.69226332 |
| 53 | Vascular calcification (HP:0004934) | 2.68973544 |
| 54 | Rhabdomyolysis (HP:0003201) | 2.68581690 |
| 55 | Systemic lupus erythematosus (HP:0002725) | 2.62681485 |
| 56 | Hypochromic microcytic anemia (HP:0004840) | 2.60722710 |
| 57 | Spastic diplegia (HP:0001264) | 2.58984623 |
| 58 | Acanthocytosis (HP:0001927) | 2.45230902 |
| 59 | Irritability (HP:0000737) | 2.45045519 |
| 60 | Myoglobinuria (HP:0002913) | 2.44389945 |
| 61 | Hypoglycemic seizures (HP:0002173) | 2.43705335 |
| 62 | Neonatal onset (HP:0003623) | 2.43256622 |
| 63 | Cerebral edema (HP:0002181) | 2.40685499 |
| 64 | Cardiovascular calcification (HP:0011915) | 2.38450073 |
| 65 | Mitral stenosis (HP:0001718) | 2.34681452 |
| 66 | Abnormal gallbladder morphology (HP:0012437) | 2.33703443 |
| 67 | Malnutrition (HP:0004395) | 2.33371155 |
| 68 | Increased serum pyruvate (HP:0003542) | 2.31872612 |
| 69 | Sensorimotor neuropathy (HP:0007141) | 2.28750934 |
| 70 | Alkalosis (HP:0001948) | 2.28668572 |
| 71 | Cholelithiasis (HP:0001081) | 2.27995035 |
| 72 | Muscle fiber inclusion bodies (HP:0100299) | 2.27083353 |
| 73 | Glomerulonephritis (HP:0000099) | 2.26593665 |
| 74 | Amyloidosis (HP:0011034) | 2.26040860 |
| 75 | Generalized aminoaciduria (HP:0002909) | 2.24668471 |
| 76 | Hydroxyprolinuria (HP:0003080) | 2.23396362 |
| 77 | Abnormality of proline metabolism (HP:0010907) | 2.23396362 |
| 78 | Enlarged kidneys (HP:0000105) | 2.22669099 |
| 79 | Cholecystitis (HP:0001082) | 2.21453828 |
| 80 | Abnormal gallbladder physiology (HP:0012438) | 2.21453828 |
| 81 | Vomiting (HP:0002013) | 2.21433296 |
| 82 | Late onset (HP:0003584) | 2.20495803 |
| 83 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.19999728 |
| 84 | Abnormality of alanine metabolism (HP:0010916) | 2.19999728 |
| 85 | Hyperalaninemia (HP:0003348) | 2.19999728 |
| 86 | Pancreatitis (HP:0001733) | 2.17906347 |
| 87 | Esophageal varix (HP:0002040) | 2.17670815 |
| 88 | Atrioventricular block (HP:0001678) | 2.15616198 |
| 89 | Facial shape deformation (HP:0011334) | 2.14700469 |
| 90 | Potter facies (HP:0002009) | 2.14700469 |
| 91 | Abnormality of glycolysis (HP:0004366) | 2.14073654 |
| 92 | Nemaline bodies (HP:0003798) | 2.13179119 |
| 93 | Abnormality of vitamin metabolism (HP:0100508) | 2.12483842 |
| 94 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.11335339 |
| 95 | Hyperuricemia (HP:0002149) | 2.09165518 |
| 96 | Increased purine levels (HP:0004368) | 2.09165518 |
| 97 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.08686287 |
| 98 | Brushfield spots (HP:0001088) | 2.07853801 |
| 99 | Proximal tubulopathy (HP:0000114) | 2.07061126 |
| 100 | Fair hair (HP:0002286) | 2.04372651 |
| 101 | Rickets (HP:0002748) | 2.02511546 |
| 102 | Oligomenorrhea (HP:0000876) | 2.01532611 |
| 103 | Cerebral palsy (HP:0100021) | 2.00793125 |
| 104 | Thrombophlebitis (HP:0004418) | 1.97998656 |
| 105 | Opisthotonus (HP:0002179) | 1.97478615 |
| 106 | Hemorrhage of the eye (HP:0011885) | 1.96463924 |
| 107 | Gingival bleeding (HP:0000225) | 1.96413029 |
| 108 | Menorrhagia (HP:0000132) | 1.95485009 |
| 109 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.93658361 |
| 110 | Abnormality of the gallbladder (HP:0005264) | 1.92829523 |
| 111 | Heart block (HP:0012722) | 1.92345255 |
| 112 | Hypertriglyceridemia (HP:0002155) | 1.91978588 |
| 113 | Abnormal cartilage morphology (HP:0002763) | 1.91754120 |
| 114 | Status epilepticus (HP:0002133) | 1.90717628 |
| 115 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.88364147 |
| 116 | Exercise-induced muscle cramps (HP:0003710) | 1.87500824 |
| 117 | Hypophosphatemic rickets (HP:0004912) | 1.83670715 |
| 118 | Poikilocytosis (HP:0004447) | 1.81921779 |
| 119 | Glycosuria (HP:0003076) | 1.79722140 |
| 120 | Abnormality of urine glucose concentration (HP:0011016) | 1.79722140 |
| 121 | Elevated hepatic transaminases (HP:0002910) | 1.78807422 |
| 122 | Renal cortical cysts (HP:0000803) | 1.77507834 |
| 123 | Reduced antithrombin III activity (HP:0001976) | 1.73567243 |
| 124 | Abnormal atrioventricular conduction (HP:0005150) | 1.73296646 |
| 125 | Abnormal biliary tract physiology (HP:0012439) | 1.70872281 |
| 126 | Bile duct proliferation (HP:0001408) | 1.70872281 |
| 127 | Osteomalacia (HP:0002749) | 1.70203728 |
| 128 | Retinal atrophy (HP:0001105) | 1.66921427 |
| 129 | Purpura (HP:0000979) | 1.62458372 |
| 130 | Hyperphosphaturia (HP:0003109) | 1.61680368 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.18748329 |
| 2 | SIK1 | 4.74651065 |
| 3 | OBSCN | 4.32657990 |
| 4 | FGFR4 | 4.31550263 |
| 5 | ERN1 | 4.20616099 |
| 6 | PHKG1 | 3.46012390 |
| 7 | PHKG2 | 3.46012390 |
| 8 | INSRR | 2.81279080 |
| 9 | ERBB4 | 2.74326293 |
| 10 | TAOK3 | 2.45145606 |
| 11 | NTRK3 | 2.42228181 |
| 12 | TRIB3 | 2.32527548 |
| 13 | MST1R | 2.23262744 |
| 14 | MAP2K4 | 2.17596857 |
| 15 | PKN2 | 2.10838779 |
| 16 | MARK1 | 2.03206588 |
| 17 | MAPK11 | 1.83185031 |
| 18 | PIK3CA | 1.72860763 |
| 19 | LATS1 | 1.59383061 |
| 20 | FLT3 | 1.52444654 |
| 21 | PTK6 | 1.50680668 |
| 22 | DAPK2 | 1.46676978 |
| 23 | FGFR2 | 1.45873756 |
| 24 | PIK3CG | 1.43968546 |
| 25 | MAPKAPK3 | 1.39874844 |
| 26 | TYK2 | 1.38912066 |
| 27 | FRK | 1.35632296 |
| 28 | ABL2 | 1.32971377 |
| 29 | PINK1 | 1.32551425 |
| 30 | CAMK1 | 1.30378104 |
| 31 | MAP3K7 | 1.23140491 |
| 32 | NEK6 | 1.22385141 |
| 33 | PRKAA2 | 1.20584851 |
| 34 | GRK6 | 1.18252572 |
| 35 | STK38L | 1.18064896 |
| 36 | JAK2 | 1.15202234 |
| 37 | NEK9 | 1.13667740 |
| 38 | ERBB2 | 1.10055808 |
| 39 | EPHA4 | 1.07839456 |
| 40 | PAK6 | 1.07727005 |
| 41 | CAMK1D | 1.03008946 |
| 42 | NTRK2 | 1.02518145 |
| 43 | PRKG1 | 0.96124974 |
| 44 | KDR | 0.96007955 |
| 45 | MYLK | 0.94920042 |
| 46 | RIPK1 | 0.94132098 |
| 47 | PRKCZ | 0.93193022 |
| 48 | EPHB1 | 0.92898487 |
| 49 | SGK3 | 0.92095925 |
| 50 | JAK1 | 0.91018508 |
| 51 | PRKACA | 0.90999416 |
| 52 | WNK3 | 0.88633551 |
| 53 | MAPK4 | 0.86014247 |
| 54 | SGK1 | 0.85406993 |
| 55 | TTN | 0.84303235 |
| 56 | MAP2K3 | 0.84226682 |
| 57 | MET | 0.83838375 |
| 58 | MAPK12 | 0.82338074 |
| 59 | DYRK1B | 0.80656062 |
| 60 | TBK1 | 0.79983536 |
| 61 | PRKAA1 | 0.78693683 |
| 62 | PRKACG | 0.78501420 |
| 63 | CAMK2B | 0.78454485 |
| 64 | SGK2 | 0.78193143 |
| 65 | CAMKK2 | 0.77138932 |
| 66 | MAPK13 | 0.76892763 |
| 67 | PDK4 | 0.76609866 |
| 68 | PDK3 | 0.76609866 |
| 69 | GSK3A | 0.74509230 |
| 70 | SGK223 | 0.73805698 |
| 71 | SGK494 | 0.73805698 |
| 72 | CDK6 | 0.73604854 |
| 73 | RPS6KA3 | 0.73378887 |
| 74 | MAP3K10 | 0.73001363 |
| 75 | WNK4 | 0.72267116 |
| 76 | TIE1 | 0.72220498 |
| 77 | CAMK2A | 0.71874795 |
| 78 | NLK | 0.68739977 |
| 79 | MAP3K3 | 0.68735639 |
| 80 | MAP4K2 | 0.67980126 |
| 81 | MAPK15 | 0.67868310 |
| 82 | EPHA3 | 0.67729099 |
| 83 | FGFR3 | 0.67681771 |
| 84 | MAP2K6 | 0.67483441 |
| 85 | CAMK2G | 0.65964794 |
| 86 | MAP3K14 | 0.64829271 |
| 87 | CAMKK1 | 0.62702065 |
| 88 | MAP3K11 | 0.61567196 |
| 89 | CAMK2D | 0.60550975 |
| 90 | CDK5 | 0.59720826 |
| 91 | ADRBK2 | 0.59260130 |
| 92 | PDPK1 | 0.58443672 |
| 93 | OXSR1 | 0.58024765 |
| 94 | PTK2 | 0.57670516 |
| 95 | PRKCE | 0.56893577 |
| 96 | FER | 0.56741068 |
| 97 | CSK | 0.55136084 |
| 98 | MUSK | 0.54861627 |
| 99 | TNK2 | 0.54450913 |
| 100 | GRK5 | 0.54294968 |
| 101 | CAMK1G | 0.53838467 |
| 102 | BMPR1B | 0.53562955 |
| 103 | NEK1 | 0.53438110 |
| 104 | AKT2 | 0.53382643 |
| 105 | IRAK3 | 0.52994275 |
| 106 | PRKACB | 0.52931006 |
| 107 | LMTK2 | 0.52787526 |
| 108 | TRPM7 | 0.51318409 |
| 109 | ICK | 0.49981971 |
| 110 | MAPK7 | 0.49492749 |
| 111 | MAP2K1 | 0.49090528 |
| 112 | TGFBR2 | 0.47697301 |
| 113 | DYRK1A | 0.47136622 |
| 114 | CASK | 0.46280645 |
| 115 | MAPKAPK5 | 0.45911118 |
| 116 | TAOK2 | 0.45554313 |
| 117 | IGF1R | 0.45403370 |
| 118 | CSNK1A1 | 0.44004350 |
| 119 | CSNK1G1 | 0.43515685 |
| 120 | PRKCQ | 0.43033100 |
| 121 | PRKCG | 0.42835735 |
| 122 | CSF1R | 0.42192134 |
| 123 | RET | 0.41497521 |
| 124 | ROCK1 | 0.38952859 |
| 125 | BMX | 0.37850247 |
| 126 | PDK1 | 0.36644825 |
| 127 | IKBKE | 0.35794694 |
| 128 | PRKD3 | 0.35769478 |
| 129 | STK38 | 0.35661333 |
| 130 | MAP3K6 | 0.34142082 |
| 131 | GRK1 | 0.33587752 |
| 132 | PAK3 | 0.33235226 |
| 133 | MTOR | 0.32202117 |
| 134 | MAP3K13 | 0.31955207 |
| 135 | MAP3K5 | 0.31799078 |
| 136 | CAMK4 | 0.29668125 |
| 137 | PDK2 | 0.29577292 |
| 138 | EGFR | 0.29272267 |
| 139 | PKN1 | 0.28204136 |
| 140 | PDGFRA | 0.27860080 |
| 141 | PRKCA | 0.27706982 |
| 142 | CSNK1G2 | 0.26780516 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.29019149 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.81449858 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.32215136 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.26541367 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.04855453 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.68340837 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.67926575 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.67027488 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.55310031 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.54869372 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.53421393 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.47830449 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.28197638 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.24094802 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.10756490 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.08473162 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.07209398 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.93404034 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.90870872 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.88144560 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86625051 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.84712004 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.81659518 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76940461 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.74774961 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72630705 |
| 27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.71310961 |
| 28 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.68022261 |
| 29 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.66283909 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61583105 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.58659328 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.58268276 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.54619732 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.52825523 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.50522168 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.44849046 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.42760235 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.36045691 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.35500511 |
| 40 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30022799 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.29996157 |
| 42 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27832988 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.25510774 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.20404643 |
| 45 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.19752250 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.16709449 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.14934683 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14174235 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.13861546 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.11331057 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08629509 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99194177 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94606195 |
| 54 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93980830 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.90992286 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.89536775 |
| 57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87798814 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.82963964 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.82169873 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76718502 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75473753 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.74467169 |
| 63 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70908517 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.67239256 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.60064666 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46414974 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33019420 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31520086 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.29756696 |
| 70 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.28614795 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28074680 |
| 72 | * One carbon pool by folate_Homo sapiens_hsa00670 | 0.27952470 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.27085004 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25308500 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.25108127 |
| 76 | Circadian rhythm_Homo sapiens_hsa04710 | 0.18847087 |
| 77 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.17381896 |
| 78 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.17246904 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.17172921 |
| 80 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.11639847 |
| 81 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.06545119 |
| 82 | GABAergic synapse_Homo sapiens_hsa04727 | 0.06422566 |
| 83 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.05953847 |
| 84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.05574608 |
| 85 | Pertussis_Homo sapiens_hsa05133 | 0.03915406 |
| 86 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.02311938 |
| 87 | Insulin secretion_Homo sapiens_hsa04911 | 0.01802628 |
| 88 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.00329976 |
| 89 | Renin secretion_Homo sapiens_hsa04924 | 0.00220531 |
| 90 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2384886 |
| 91 | Bladder cancer_Homo sapiens_hsa05219 | -0.2328177 |
| 92 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2220481 |
| 93 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2196232 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1771882 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | -0.1753339 |
| 96 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1750198 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1733233 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1721918 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | -0.1642620 |
| 100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1480666 |
| 101 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1367597 |
| 102 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1295035 |
| 103 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1222743 |
| 104 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1082415 |
| 105 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1041279 |
| 106 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0936455 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0741452 |
| 108 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0740127 |
| 109 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0648872 |
| 110 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0549277 |
| 111 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0538356 |
| 112 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0494420 |
| 113 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.0425515 |
| 114 | Amphetamine addiction_Homo sapiens_hsa05031 | -0.0370210 |
| 115 | Glutamatergic synapse_Homo sapiens_hsa04724 | -0.0188171 |
| 116 | Nicotine addiction_Homo sapiens_hsa05033 | -0.0052857 |

